| Product Code: ETC6736501 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Antiviral Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Antiviral Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Antiviral Drugs Market - Industry Life Cycle |
3.4 China Antiviral Drugs Market - Porter's Five Forces |
3.5 China Antiviral Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.6 China Antiviral Drugs Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 China Antiviral Drugs Market Revenues & Volume Share, By Distribution Channels, 2021 & 2031F |
4 China Antiviral Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral diseases in China |
4.2.2 Growing awareness about the importance of antiviral drugs for public health |
4.2.3 Technological advancements in drug development and manufacturing in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High cost associated with research and development of antiviral drugs |
4.3.3 Competition from generic drugs and alternative therapies |
5 China Antiviral Drugs Market Trends |
6 China Antiviral Drugs Market, By Types |
6.1 China Antiviral Drugs Market, By Disease Indication |
6.1.1 Overview and Analysis |
6.1.2 China Antiviral Drugs Market Revenues & Volume, By Disease Indication, 2021- 2031F |
6.1.3 China Antiviral Drugs Market Revenues & Volume, By Hepatitis Virus Infection, 2021- 2031F |
6.1.4 China Antiviral Drugs Market Revenues & Volume, By HIV Infection, 2021- 2031F |
6.1.5 China Antiviral Drugs Market Revenues & Volume, By Respiratory Virus Infection, 2021- 2031F |
6.1.6 China Antiviral Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Antiviral Drugs Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 China Antiviral Drugs Market Revenues & Volume, By Branded Drugs, 2021- 2031F |
6.2.3 China Antiviral Drugs Market Revenues & Volume, By Generic Drugs, 2021- 2031F |
6.3 China Antiviral Drugs Market, By Distribution Channels |
6.3.1 Overview and Analysis |
6.3.2 China Antiviral Drugs Market Revenues & Volume, By Hospital Pharmacy Store, 2021- 2031F |
6.3.3 China Antiviral Drugs Market Revenues & Volume, By Retail Pharmacy Store, 2021- 2031F |
6.3.4 China Antiviral Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Antiviral Drugs Market Import-Export Trade Statistics |
7.1 China Antiviral Drugs Market Export to Major Countries |
7.2 China Antiviral Drugs Market Imports from Major Countries |
8 China Antiviral Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for antiviral drugs conducted in China |
8.2 Research and development expenditure in the Chinese pharmaceutical industry |
8.3 Adoption rate of new antiviral drugs in clinical practice |
8.4 Number of partnerships and collaborations between Chinese pharmaceutical companies and international players |
8.5 Government funding allocated for antiviral drug research and development in China |
9 China Antiviral Drugs Market - Opportunity Assessment |
9.1 China Antiviral Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.2 China Antiviral Drugs Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 China Antiviral Drugs Market Opportunity Assessment, By Distribution Channels, 2021 & 2031F |
10 China Antiviral Drugs Market - Competitive Landscape |
10.1 China Antiviral Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Antiviral Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here